Issues of epidemiology, verification and prevention of chronic HBV infection from donors and HIV-infected patients (literature review).

  • Authors: Eremeeva Z.1,2, Fazylov V.K.3, Siraziev A.4
  • Affiliations:
    1. Republican Clinical Dermatology and Venereology Dispensary
    2. Kazan State Medical University
    3. КГМА - филиал ФГБОУ ДПО РМАНПО Минздрава России, 4 Марийский государственный университет, 5 ГАУЗ «РЦПБ СПИД и ИЗ МЗ РТ»
    4. КГМА - филиал ФГБОУ ДПО РМАНПО Минздрава России, Марийский государственный университет,
  • Section: Reviews
  • Submitted: 27.12.2024
  • Accepted: 11.04.2025
  • Published: 09.07.2025
  • URL: https://rjeid.com/1560-9529/article/view/643498
  • DOI: https://doi.org/10.17816/EID643498
  • ID: 643498


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review presents current aspects of latent hepatitis B in the structure of chronic bv infection: an analysis of hepatitis b incidence for 2001-2023 in the republic of tatarstan is conducted, data on the prevalence of latent hepatitis B in different population groups are presented: among donors and hiv-infected individuals. The review presents preliminary data influencing the formation of latent hepatitis B in patients with hiv. 68 sources were analyzed, including 55 works by domestic and 13 foreign authors

Full Text

Restricted Access

About the authors

Zhanna Eremeeva

Republican Clinical Dermatology and Venereology Dispensary;Kazan State Medical University

Author for correspondence.
Email: fin5zhannik@rambler.ru
ORCID iD: 0000-0003-2711-0624

PhD, assistant of the Department of Epidemiology and Evidence-Based Medicine, epidemiologist

Russian Federation

Vildan Kh. Fazylov

КГМА - филиал ФГБОУ ДПО РМАНПО Минздрава России,
4 Марийский государственный университет,
5 ГАУЗ «РЦПБ СПИД и ИЗ МЗ РТ»

Email: fazylov4@inbox.ru
ORCID iD: 0000-0003-4333-6316
SPIN-code: 3283-1607

д.м.н., профессор кафедры инфекционных болезней

Airat Siraziev

КГМА - филиал ФГБОУ ДПО РМАНПО Минздрава России,
Марийский государственный университет,

Email: sirazievair95@mail.ru
ORCID iD: 0009-0004-6663-7669
SPIN-code: 1286-6399

References

  1. Hepatitis B. WHO. April 9, 2024. [Electronic resource]. Available from: https://www.who.int/ru/newsroom/factsheets/detail/hepatitisb. Date of access: 12.18.2024.
  2. Mirojov GK Interaction of hepatitis viruses (HBV, HDV, HCV) in their combined infection in the development of chronic diffuse liver lesions // Problemy gastroenterologii.. 2022;1: 12-16. (In Russ).
  3. Mikhailova YuV, Sterlikov SA, Gromov AV Mortality from viral hepatitis in the Russian Federation (analytical review) // Sovremennye problemy zdravookhraneniya i meditsinskoi statistiki. 2022;1:414-437. (In Russ). doi: 10.24412/2312293520221414437.
  4. Perz JF, Armstrong GL, Leigh A Farrington the contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide // Journal of Hepatology. 2006; 45: 529–538.
  5. Lyubimtseva OA, Kashuba EA, Fedorchuk AO et all. Retrospective analysis of fatal outcomes in patients with parenteral viral hepatitis // Vyatskii meditsinskii vestnik.. 2020;3 (67): 69-73. (In Russ). doi: 10.24411/22207880202010110.
  6. German EN Skrytaya infektsiya virusom gepatita V v strukture bol'nykh s khronicheskim techeniem infektsii virusom gepatita S. [dissertation]. Moskva, 2010. Available from: https://medical-diss.com/docreader/317183/d?#?page=1. (In Russ). Date of access: 12/18/2024.
  7. Asrankulova DB Features of the course of perinatal viral hepatitis // Novyi den' v meditsine.. 2019; 4 (28): 133-135. (In Russ).
  8. Akhmedova MD, Tashpulatova ShA, Ikhtiyarova GA at all. Chronic viral hepatitis B and D in pregnant women: prevalence, course and outcomes // Zhurnal infektologii. 2021; 13(2): 29-37. (In Russ). doi: 10.22625/2072673220211322937.
  9. Shilova IV, Ostankova YuV, Goryacheva LG et all. HBV infection in children with perinatal infection. A clinical case of familial hepatitis B // Zhurnal infektologii. 2021; 13(3): 120-124. (In Russ). doi: 10.22625/207267322021133120124.
  10. Yakubova FM, Fazylov VKh Immunoprophylaxis of perinatal infection with hepatitis B virus in family foci // Prakticheskaya meditsina. 2014; 7 (83): 133-136. (In Russ).
  11. Inoyatova FI, Abdullaeva F G, Inogamova GZ Epidemiological patterns of chronic HBV infection in family foci // Detskie infektsii. 2016; 15(3): 62-65. (In Russ).
  12. Sleptsova SS, Mikhailov MI, Efimov EE et all. Medical and social monitoring of the population for parenteral viral hepatitis as a basis for creating an organizational model for the prevention and treatment of viral hepatitis and primary liver cancer in Yakutia // Vestnik SeveroVostochnogo federal'nogo universiteta im. M.K. Ammosova. Seriya: Meditsinskie nauki. 2018;(12): 66-71. (In Russ). doi: 10.25587/SVFU.2018.3(13).18857.
  13. Zairova MG, Tobokalova ST, Nogoybaeva KA et all. Epidemiological features of familial foci of hepatitis B, C and D // Vestnik Kyrgyzskoi gosudarstvennoi meditsinskoi akademii imeni I.K. Akhunbaeva. 2015; 4: 135-138. (In Russ).
  14. Ulyukin IM, Orlova ES, Bulankov YuI Occult hepatitis «B» in the light of ensuring infectious safety of blood transfusions and monitoring antiviral therapy of the disease // Vestnik Sankt-Peterburgskogo universiteta. Meditsina. 2015; 4: 156-173. (In Russ).
  15. Shibaeva EO, Ponyatishina MV HBsAg negative phase of chronic hepatitis B in hospital patients // Zdorov'e osnova chelovecheskogo potentsiala: problemy i puti ikh resheniya. 2014; 9(2): 709-713. (In Russ).
  16. Esaulenko EV, Sukhoruk AA, Ponyatishina MV Clinical and laboratory characteristics of occult hepatitis B // Zhurnal infektologii. 2016; 8(1): 66-72. (In Russ).
  17. Semenov AV, Ostankova YuV Occult (latent) hepatitis B: problems of laboratory diagnostics // Infektsionnye bolezni: novosti, mneniya, obuchenie. 2019. 2019; S8 3 (30): 61-69. (In Russ).
  18. Agaeva SCh, Gidayatov AA Occult infection of hepatitis B virus in patients with chronic hepatitis C during treatment with direct-acting antiviral drugs // Sibirskii meditsinskii zhurnal (Irkutsk). 2018; 154(3): 36-39. (In Russ).
  19. Tupoleva TA Latent form of infection caused by hepatitis B virus // Gematologiya i transfuziologiya. 2018; 63(2): 166-173. (In Russ). doi: 10.25837/HAT.2018.68..2..007.
  20. Aleshkin VA, Zubkin ML, Selkova EP et all. Epidemiological and clinical significance of «occult» HBV infection // Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2015; 4: 55-64. (In Russ).
  21. Zhdanov KV, Kozlov KV Viral hepatitis: A textbook for residents and doctors undergoing training in the system of postgraduate professional education. St. Petersburg: OOO «Modern», 2019. 148 p. ISBN 9785604296400. (In Russ).
  22. Mukhin MA Reference. on hepatology. Moscow: Litera, 2009. 399 p. (In Russ).
  23. Gabdrakhmanov IA, Kozlov KV, Sukachev VS et al. The relationship between covalently closed circular deoxyribonucleic acid and clinical and virological parameters in patients with chronic viral hepatitis B // Vestnik Rossiiskoi Voenno-meditsinskoi akademii. 2016; 1(53): 234-240. (In Russ).
  24. Yushchuk ND, Ivashkin VD, Zhdanov KV et al. Methodical recommendations. Protocols for dispensary observation and treatment of patients with chronic viral hepatitis B // Moscow, 2013. P. 79. (In Russ).
  25. Enaleeva DSh, Fazylov VKh, Sozinov AS Chronic viral hepatitis B, C and D: a guide for physicians. Moscow: Limited Liability Company Izdatelskaya Gruppa «GEOTARMedia», 2015. 192 p. ISBN 9785970432556(In Russ).
  26. Lampertico P, Agarwal K, Berg T et all. European Association for the Study of the Liver. EASL 2017 Clinical Practice G uidelines: management of chronic hepatitis B virus infection // J. Hepatol. 2017; 67(2): 370-398.
  27. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2014. Stockholm: ECDC; 2015. [Electronic resource]. Available from: http://ecdc. europa.eu/en/publications/Publications/hivaidssurveillancein Europe 2014. pdf (Accessed 05.12.24).
  28. Altindis M, Uslan I, Cetinkaya Z Investigation of hemodialysis patients in terms of the presence of occult hepatitis B // Mikrobiyol. Bul. 2007; 41(2): 227–233.
  29. French AL, Operskalski E, Peters M et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women // J. Infect. Dis. 2007; 195(10): 1437–1442.
  30. Pollicino T, Raffa G, Costantino L et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma // Hepatology. 2007; 45: 277-285.
  31. Ivashkin VT, Morozova MA, Maevskaya MV, et al. Risk factors for the development of hepatocellular carcinoma // RZHGGK. 2009; 1: 416. (In Russ).
  32. Donato F, Gelatti U, Limina RM, Fattovich G Souther Europe as an example of interaction between various enviror mental factors: a systematic review of the epidemiologic evidence // Oncogene. 2006;25: 375-670.
  33. Chemin I, Zoulim F, Merle P High incidence of hepatitis B infections among chronic hepatitis cases of unknown etiology // J. Hepatology. 2001; 34(3): 447–454.
  34. Nikitina GYu, Voznesensky SL, Mauletova DN Latent HBV infection // Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2012; 5: 55–61. (In Russ).
  35. Batskikh SN Post-hepatitis B: a resolved problem or imaginary well-being? // Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2021; 31(1): 719. (In Russ). doi: 10.22416/138243762021311719.
  36. Filippova AA, Faenko AP, Golosova SA, et al. Five-year experience of ensuring infectious safety of donor blood and its components of the Federal State Budgetary Institution of Health Care, the Blood Center of the Federal Medical and Biological Agency of Russia // Analiz riska zdorov'yu. 2022; 3: 110-118. (In Russ). doi: 10.21668/health.risk/2022.3.10.
  37. Fazylov VKh Etiological and pathogenetic aspects of diagnostics and treatment of viral hepatitis // Kazanskii meditsinskii zhurnal. 2013; 6: 785–792. (In Russ).
  38. Enaleeva DSh, Fazylov VKh, Sozinov AS Chronic viral hepatitis B, C and D: A manual for physicians, Moscow: MEDpressinform, 2011; 464 (In Russ).
  39. Ostankova YuV, Serikova EN, Shirshova NYu et al. Prevalence of latent chronic hepatitis B in blood donors in St. Petersburg // Infektsiya i immunitet. 2023; 13(6): 1129-1140. (In Russ). doi: 10.15789/22207619POO14480.
  40. Kozhemyako OV, Krivonosova NV, Kurmanova OV Selective screening for the presence of antibodies to the hepatitis B virus core antigen in donors in Khabarovsk // Zdravookhranenie Dal'nego Vostoka.. 2023;2(96): 16-21. (In Russ). doi: 10.33454/17281261202321621.
  41. Abakarov RR, Tikhomirov DS, Tupoleva TA, et al. Frequency of detection of antibodies to the core antigen of the hepatitis B virus in donors of blood and its components in four constituent entities of the Russian Federation // Gematologiya i transfuziologiya. 2021; 66(2): 242-252. (In Russ). doi: 10.35754/023457302021662242252.
  42. Boumbali S, Balde TAL, Semenov AV et al. Prevalence of markers of viral hepatitis B among blood donors in the Republic of Guinea // Voprosy virusologii. 2022; 67 (1): 59-68. (In Russ). doi : 10.36233/0507408892.
  43. Abdukadirova MA Prognostic markers of chronicity of viral hepatitis C // Immunologiya. 2002; 23(1): 47–50. (In Russ).
  44. Eremeeva ZhG, Fazylov VK. Detection of occult hepatitis B during testing of donor blood // Vestnik RGMU. Moscow. 2017; 1: 66-69. (In Russ).
  45. Eremeeva ZhG, Fazylov VKh Donor blood as a factor in the transmission of hepatitis B virus with the formation of chronic HBV infection: issues of verification, control and prevention (literature review) // Transfuziologiya. 2018;19(3):61-73. (In Russ).
  46. Fazylov VKh, Eremeeva ZhG, Turaev RG Ways to optimize the diagnosis of latent hepatitis B in blood donors // Infektsionnye bolezni: novosti, mneniya, obuchenie. 2023; Vol.12,1(44): 54-61. (In Russ). doi: 10.33029/2305349620231215461.
  47. Zaitsev IA Occult HBV infection // Aktual'naya infektologiya. 2018; 6(3): 132-140. (In Russ). doi: 10.22141/2312413x.6.3.2018.136646.
  48. Nikolskaya MV, Zykova OA Features of the course of chronic viral hepatitis in HIV-infected patients // Akademicheskaya nauka problemy i dostizheniya VIII : Materialy VIII mezhdunarodnoi nauchnoprakticheskoi konferentsii. North Charleston, USA, February 15-16, 2016. Vol. 1. North Charleston, USA: CreateSpace, 2016: 49-51. EDN VNPZKF. (In Russ).
  49. Makhmanurov AA, Tursunov RA, Abdikerimov MM et all. Features of the course of chronic viral hepatitis C in HIV-infected patients // Vestnik Avitsenny. 2011. No. 4. Available from: https://cyberleninka.ru/article/n/osobennostitecheniyahronicheskogovirusnogogepatitasuvichinfitsirovannyhbolnyh. Date of access: 20.11.2024. (In Russ).
  50. Bazykina EA, Turkutyukov VB, Trotsenko OE et all. Prevalence and molecular genetic characteristics of hepatitis B virus in HIV-positive individuals in the Far Eastern region // Infektsiya i immunitet. 2019; 9(1): 183-192. (In Russ). doi: 10.15789/2220761920191183192.
  51. Pokrovsky VV, Ladnaya NN Human immunodeficiency virus in the Russian Federation in 2023 // Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2024; 14 (3): 2129. (In Russ). doi: 10.18565/epidem.2024.14.3.219.
  52. Sorinson SN Viral hepatitis St. Petersburg: TEZA, 1998. 325 p. (In Russ).
  53. Kudryavtseva EN, Korabelnikova MI, Panasyuk YaV et al. Federal «Register of Patients with Viral Hepatitis» a universal tool for multifactorial epidemiological analysis // Epidemiologiya i infektsionnye bolezni. Aktual'nye voprosy. 2024; 14(1): 22-30. (In Russ). doi: 10.18565/epidem.2023.14.1.2230.
  54. Baudi I., Iijima S., Chin'ombe N., et al. Molecular epidemiology of coinfection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe // J Med Virol. 2016 Jul 26. doi:: 10.1002/jmv.24641. [Epub ahead of print]
  55. Beguelin C, Moradpour D, Sahli R, et all. Hepatitis deltaassociated mortality in HIV/HBVcoinfected patients // Kaohsiung J Med Sci. 2016; Oct. Vol. 32(10): 526-530. doi:: 10.1016/j.kjms.2016.08.004. Epub 2016 Sep 18.
  56. Buster EH, Hansen BE, Lau GK et al. Factors that predict response of patients with hepatitis B.
  57. G j^rd e LI, Shepherd L, Jablonowska E, et all. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Viruscoinfected Individuals From 2001 to 2014: A Multicohort Study // Clin Infect Dis. 2016; 63(6): 8219. doi:: 10.1093/cid/ciw380. Epub 2016 Jun 15.
  58. Liwen I, JanuszkiewiczLewandowska D, Nowak J TT virus characteristics, occurrence and routes of transmission // Przegl Epidemiol. 2002. Vol. 56(1). P. 919-928. doi: 10.3748/wjg.v12.i32.5122 PMCID: PMC4088008
  59. Guimaraes Nebenzahl H, Lopes A, Castro R, Pereira F Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. // S Afr Med J. 2013; 103 (3): 186-188.
  60. Shchemelev AN, Ostankova YuV, Zueva EB et all. Characteristics of hepatitis B virus and human immunodeficiency virus among patients with HIV/HBV coinfection from the Republic of Guinea // Problemy osobo opasnykh infektsii. 2019;3: 118-124. (In Russ). doi: 10.21055/0370106920193118124.
  61. Lapteva NI Integratsionnaya epidemiologiya infektsii s gemokontaktnym mekhanizmom peredachi (VICh, gepatity B i C) v Respublike Sakha (Yakutiya). [dissertation]. Omsk, 2014. Available from: https://medical-diss.com/docreader/445463/a?#?page=1. Date of access: 12/18/2024. (In Russ).
  62. Kozhanova TV Pervichnaya lekarstvennaya rezistentnost' virusa gepatita V. [dissertation]. Moskva,, 2010. Available from: https://search.rsl.ru/ru/record/01005084440 Date of access: 12/18/2024. (In Russ).
  63. Sleptsov AP Viral hepatitis in Yakutia. // Siberian medical journal. 2007. No. 2. pp. 52-54. Available from: http://cyberleninka.ru/article/n/virusnyygepatitvyakutii Date of access: 09.12.2016. (In Russ).
  64. Tereshkov DV, Mitsura VM, Voropae EV et all. Combined viral infections in patients with chronic hepatic tis B: prevalence and clinical significance // Gepatologiya i gastroenterologiya. 2020; 4(2): 171-176. (In Russ). doi: 10.25298/26165546
  65. Abdukadyrova MA, Sharapov SM, Khikmatullaeva AS Possibility of using quantitative determination of HBsAg in chronic HBV infection with delta agent // Infektsionnye bolezni. 2020; 18 (4):149-152. (In Russ). doi: 10.20953/1729922520204149152.
  66. Elpayeva EA, Komissarov AB, Pisareva MM et all. A new method for determining the hepatitis B virus resistance mutation to nucleos(t)ide analogues M204I/V in patients with chronic hepatitis B // Infektsiya i immunitet. 2015; 5(3): 265-272. (In Russ).
  67. Asadi Mobarhan FA, Karlsen AA, Isaeva OV et al. Prevalence of mutations of drug resistance of the hepatitis B virus // Viral hepatitis achievements and new prospects: Sbornik tezisov XIV Vserossiiskoi konferentsii s mezhdunarodnym uchastiem, Moscow, September 12-13, 2024. Moscow: Central Research Institute of Epidemiology of Rospotrebnadzor, 2024. P. 2021. (In Russ).
  68. Tobokalova S, Bekenova DS, Zairova GM Analysis of the effectiveness of lamivudine in the treatment of chronic hepatitis B // Nauka, novye tekhnologii i innovatsii Kyrgyzstana. 2018; 8: 30-35. (In Russ).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Eco-vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80652 от 15.03.2021 . Учредитель ООО "Эко-Вектор Ай-Пи" (ОГРН 1157847215338).